Literature DB >> 33057879

Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis.

Alessandro Giollo1,2,3, Raluca B Dumitru4,5, Peter P Swoboda6, Sven Plein4,6, John P Greenwood4,6, Maya H Buch5,7,8, Jacqueline Andrews4.   

Abstract

The prevalence of undiagnosed cardiac involvement in granulomatosis with polyangiitis (GPA) is unknown. In this prospective study we investigated the utility of cardiovascular magnetic resonance (CMR) to identify myocardial abnormalities in GPA and their correlation with disease phenotype. Twenty-six patients with GPA and no cardiovascular disease or diabetes mellitus underwent contrast-enhanced CMR, including late gadolinium-enhancement (LGE), T1-mapping for native T1 and extra-cellular volume (ECV) quantification for assessment of myocardial fibrosis, cine imaging and tissue tagging for assessment of left ventricular (LV) function. Twenty-five healthy volunteers (HV) with comparable age, sex, BMI and arterial blood pressure served as controls. Patients with GPA had similar cardiovascular risk profile to HV. A focal, non-ischaemic LGE pattern of fibrosis was detected in 24% of patients and no controls (p = 0.010). Patients with myocardial LGE were less frequently PR3 ANCA (7% vs 93%, p = 0.007), and had involvement of the lower respiratory tract and skin. LGE scar mass was higher in patients presenting with renal involvement. Native T1 and ECV were higher in patients with GPA than HV; ECV was higher in those with relapsing disease, and native T1 was inversely associated with PR3 ANCA (β = - 0.664, p = 0.001). Peak systolic strain was slightly reduced in GPA compared to controls; LV ejection function was inversely correlated with disease duration (β = - 0.454, p = 0.026). Patients with GPA have significant myocardial abnormalities on CMR. ANCA, systemic involvement and disease severity were associated with myocardial fibrosis. CMR could be a useful tool for risk stratification of myocardial involvement in GPA.

Entities:  

Keywords:  ANCA; CMR; Cardiovascular disease; Granulomatosis with polyangiitis; LGE; Myocardial fibrosis; Vasculitis

Mesh:

Substances:

Year:  2020        PMID: 33057879      PMCID: PMC7969556          DOI: 10.1007/s10554-020-02066-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  49 in total

Review 1.  ANCA-associated vasculitis.

Authors:  Max Yates; Richard Watts
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

2.  The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.

Authors:  Loïc Guillevin; Christian Pagnoux; Raphaele Seror; Alfred Mahr; Luc Mouthon; Philippe Le Toumelin
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

3.  Cardiac involvement in granulomatosis with polyangiitis: a magnetic resonance imaging study of 31 consecutive patients.

Authors:  Grégory Pugnet; Hervé Gouya; Xavier Puéchal; Benjamin Terrier; André Kahan; Paul Legmann; Loïc Guillevin; Olivier Vignaux
Journal:  Rheumatology (Oxford)       Date:  2017-06-01       Impact factor: 7.580

4.  Subclinical disease as an independent risk factor for cardiovascular disease.

Authors:  L H Kuller; L Shemanski; B M Psaty; N O Borhani; J Gardin; M N Haan; D H O'Leary; P J Savage; G S Tell; R Tracy
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

5.  Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis.

Authors:  Helga Midtbø; Anne Grete Semb; Knut Matre; Tore K Kvien; Eva Gerdts
Journal:  Ann Rheum Dis       Date:  2016-06-07       Impact factor: 19.103

6.  Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).

Authors:  Matthieu Groh; Gabriella Masciocco; Elizabeth Kirchner; Arnt Kristen; Carlo Pellegrini; Shaïda Varnous; Guillermo Bortman; Mark Rosenberg; Antonio Brucato; Paul Waterworth; Edgardo Bonacina; Fabio Facchetti; Leonard Calabrese; Gina Gregorini; Juan Jose Scali; Randall Starling; Maria Frigerio; Andrea Maria D'Armini; Loïc Guillevin
Journal:  J Heart Lung Transplant       Date:  2014-02-24       Impact factor: 10.247

7.  Risk of Myocardial Infarction and Stroke in Patients With Granulomatosis With Polyangiitis (Wegener's): A Population-Based Study.

Authors:  J Antonio Aviña-Zubieta; Alice Mai; Neda Amiri; Natasha Dehghan; Ju Ann Tan; Eric C Sayre; Hyon K Choi
Journal:  Arthritis Rheumatol       Date:  2016-09-29       Impact factor: 10.995

Review 8.  Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies.

Authors:  Eline Houben; Erik L Penne; Alexandre E Voskuyl; Joost W van der Heijden; René H J Otten; Maarten Boers; Tiny Hoekstra
Journal:  Rheumatology (Oxford)       Date:  2018-03-01       Impact factor: 7.580

Review 9.  Normal values for cardiovascular magnetic resonance in adults and children.

Authors:  Nadine Kawel-Boehm; Alicia Maceira; Emanuela R Valsangiacomo-Buechel; Jens Vogel-Claussen; Evrim B Turkbey; Rupert Williams; Sven Plein; Michael Tee; John Eng; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2015-04-18       Impact factor: 5.364

10.  T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.

Authors:  Vanessa M Ferreira; Stefan K Piechnik; Erica Dall'Armellina; Theodoros D Karamitsos; Jane M Francis; Ntobeko Ntusi; Cameron Holloway; Robin P Choudhury; Attila Kardos; Matthew D Robson; Matthias G Friedrich; Stefan Neubauer
Journal:  JACC Cardiovasc Imaging       Date:  2013-09-04
View more
  2 in total

1.  Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?

Authors:  Lauren Floyd; Adam D Morris; Alexander Woywodt; Ajay Dhaygude
Journal:  Clin Kidney J       Date:  2022-01-13

2.  Chest Pain of Atypical Cause in a Young Man.

Authors:  Justyna Fijolek; Dariusz Gawryluk; Dorota Piotrowska-Kownacka; Krzysztof Ozieranski; Romuald Wojnicz; Elzbieta Wiatr
Journal:  Diagnostics (Basel)       Date:  2022-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.